Calida Therapeutics
Latest round
- Seed
Last raised
- Apr 2023
Total raised
- $2.2M
Investors
- 1
About Calida Therapeutics
Based in Paris, France, and founded in 2022, Calida Therapeutics operates as a preclinical stage biotechnology company specialising in thrombo-inflammatory disorders. The company was co-founded by Dr. Yunmei Wang and Dr. Daniel Simon. Calida is developing monoclonal antibodies that can be used to treat and prevent thrombo-inflammatory diseases that can arise in a variety of illnesses, ranging from cardiovascular disease to autoimmune disease complications. The company aims to break the molecular link between thrombosis and inflammation by limiting cross-talk between platelets and myeloid cells, preventing the chain reaction of these two events, which can cause tissue damage and life-threatening events. As of 2023, the company's product is still in preclinical testing and has yet to be commercialised.
Who invested in Calida Therapeutics
1 investor across 1 round
See all investors in Calida Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 6, 2023
Amount
$2.2M
Investors
Questions about Calida Therapeutics
Who invested in Calida Therapeutics?
Calida Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calida Therapeutics raised?
Calida Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Calida Therapeutics last raise money?
Calida Therapeutics's most recent round on record is a Seed, in Apr 2023.
What does Calida Therapeutics do?
Based in Paris, France, and founded in 2022, Calida Therapeutics operates as a preclinical stage biotechnology company specialising in thrombo-inflammatory disorders.
Where is Calida Therapeutics headquartered?
Calida Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like Calida Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Calida Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Calida Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.